Christopher Mark Hill
Impact in
-
- Immunotherapy and Immune Responses
- T-cell and B-cell Immunology
- Immune Cell Function and Interaction
-
- HER2/EGFR in Cancer Research
- CAR-T cell therapy research
Papers in
-
- Immunotherapy and Immune Responses 2
- T-cell and B-cell Immunology 2
- Immunodeficiency and Autoimmune Disorders 1
- Oncology 4
- Pancreatic and Hepatic Oncology Research 2
- Co-authors
- Carol J. Wikstrand (1 shared paper)Laura P. Hale (1 shared paper)Craig J. Reist (1 shared paper)Charles N. Pegram (1 shared paper)Roger E. McLendon (1 shared paper)David K. Moscatello (1 shared paper)Surinder K. Batra (1 shared paper)Shekar N. Kurpad (1 shared paper)
- Journals
- International Journal of Radiation Oncology*Biology*Physics (2 papers)Annals of Epidemiology (1 paper)European Journal of Immunology (1 paper)Cancer Research (1 paper)Clinical Cancer Research (1 paper)
- Partner nations
- United StatesGermanyUnited Kingdom
In The Last Decade
Christopher Mark Hill
10 papers receiving 637 citations
Peers
Comparison fields: 5 of 65
- Immunology 233
- Oncology 245
- Genetics 78
- Radiology, Nuclear Medicine and Imaging 161
- Cancer Research 39
Countries citing papers authored by Christopher Mark Hill
This map shows the geographic impact of Christopher Mark Hill's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Christopher Mark Hill with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Christopher Mark Hill more than expected).
Fields of papers citing papers by Christopher Mark Hill
This network shows the impact of papers produced by Christopher Mark Hill. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Christopher Mark Hill. The network helps show where Christopher Mark Hill may publish in the future.
Co-authors
The 25 scholars most cited alongside Christopher Mark Hill, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | Monoclonal antibodies against EGFRvIII are tumor specific and react with breast and lung carcinomas and malignant gliomas. | 1995 | 403 |
| 2 | 1992 | 126 | |
| 3 | 2000 | 68 | |
| 4 | 1999 | 33 | |
| 5 | 1989 | 14 | |
| 6 | 2016 | 7 | |
| 7 | 2025 | 2 | |
| 8 | 2022 | 1 | |
| 9 | Consensus statement on cereals, fibre and colorectal and breast cancers | 1998 | 1 |
| 10 | 2022 | 1 | |
| 11 | 2024 | 0 |
About Christopher Mark Hill
Christopher Mark Hill is a scholar working on Immunology, Oncology, Cancer Research, Radiology, Nuclear Medicine and Imaging and Epidemiology, having authored 11 papers that have together received 656 indexed citations. Recurring topics across this work include Cancer Genomics and Diagnostics (2 papers), Immunotherapy and Immune Responses (2 papers), T-cell and B-cell Immunology (2 papers), Pancreatic and Hepatic Oncology Research (2 papers), Monoclonal and Polyclonal Antibodies Research (2 papers), vaccines and immunoinformatics approaches (1 paper), Immunodeficiency and Autoimmune Disorders (1 paper) and Diabetes and associated disorders (1 paper). The work is most often cited by research in Immunology (233 citations), Oncology (245 citations), Genetics (78 citations), Radiology, Nuclear Medicine and Imaging (161 citations) and Cancer Research (39 citations). Christopher Mark Hill has collaborated with scholars based in United States, Germany and United Kingdom. Frequent co-authors include Carol J. Wikstrand, Laura P. Hale, Craig J. Reist, Charles N. Pegram, Roger E. McLendon, David K. Moscatello, Surinder K. Batra, Shekar N. Kurpad, Peter A. Humphrey and Colin R.A. Hewitt. Their work appears in journals such as International Journal of Radiation Oncology*Biology*Physics, Annals of Epidemiology, European Journal of Immunology, Cancer Research and Clinical Cancer Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.